Lunai Bioworks Inc. Form SCHEDULE 13D/A — Oct 15, 2026
William Anderson Wittekind filed Amendment No. 25 to his Schedule 13D on Lunai Bioworks Inc., reporting beneficial ownership of 226,665 shares, or 4.5% of the class. The amendment reflects shares outstanding of 5,034,452 as reported in the issuer's Form 10-K filed October 13, 2026; Wittekind no longer owns more than 5% of the company. His stake traces to the January 2018 merger among DanDrit BioTech USA, Renovaro Biopharma (then Enochian Biopharma), and his LLC Weird Science.
Key figures
- Shares Owned
- 226665
- Percent of class
- 4.5%
- Sole voting power
- 70083
- Shares outstanding
- 5034452
- Shared voting power
- 156582
AI analysis
Red flags2 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.